MARROSU, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 360.518
NA - Nord America 19.036
AS - Asia 8.139
SA - Sud America 1.142
AF - Africa 162
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 24
Totale 389.055
Nazione #
IT - Italia 354.852
US - Stati Uniti d'America 18.788
SG - Singapore 3.109
CN - Cina 3.037
UA - Ucraina 1.417
SE - Svezia 1.163
BR - Brasile 913
DE - Germania 765
FI - Finlandia 732
VN - Vietnam 663
GB - Regno Unito 535
FR - Francia 477
HK - Hong Kong 275
IN - India 192
KR - Corea 149
CA - Canada 141
NL - Olanda 132
BD - Bangladesh 93
JP - Giappone 89
IQ - Iraq 83
AR - Argentina 82
RU - Federazione Russa 77
PK - Pakistan 59
MX - Messico 58
TR - Turchia 57
PL - Polonia 55
ES - Italia 47
AT - Austria 43
UZ - Uzbekistan 42
BE - Belgio 38
CH - Svizzera 37
IR - Iran 36
ZA - Sudafrica 34
MA - Marocco 33
ID - Indonesia 32
VE - Venezuela 29
CO - Colombia 27
EC - Ecuador 27
IE - Irlanda 27
AU - Australia 26
PH - Filippine 26
EU - Europa 22
SA - Arabia Saudita 22
AE - Emirati Arabi Uniti 20
AZ - Azerbaigian 20
KE - Kenya 20
CL - Cile 19
IL - Israele 19
JO - Giordania 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
TH - Thailandia 15
PY - Paraguay 14
BO - Bolivia 12
CU - Cuba 12
LT - Lituania 12
MY - Malesia 12
UY - Uruguay 11
PT - Portogallo 10
TW - Taiwan 10
DO - Repubblica Dominicana 9
SI - Slovenia 9
BG - Bulgaria 8
EG - Egitto 8
JM - Giamaica 8
LB - Libano 8
PE - Perù 8
RO - Romania 8
DZ - Algeria 7
ET - Etiopia 7
NZ - Nuova Zelanda 7
OM - Oman 7
DK - Danimarca 6
GE - Georgia 6
GR - Grecia 6
HR - Croazia 6
KZ - Kazakistan 6
LK - Sri Lanka 6
MD - Moldavia 6
MU - Mauritius 6
PA - Panama 6
AL - Albania 5
EE - Estonia 5
NG - Nigeria 5
NP - Nepal 5
AO - Angola 4
BY - Bielorussia 4
CR - Costa Rica 4
HU - Ungheria 4
LU - Lussemburgo 4
MK - Macedonia 4
PS - Palestinian Territory 4
CY - Cipro 3
GA - Gabon 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
QA - Qatar 3
TT - Trinidad e Tobago 3
BW - Botswana 2
Totale 389.016
Città #
Cagliari 347.559
Uta 5.226
Fairfield 1.686
Woodbridge 1.597
Ashburn 1.571
Singapore 1.479
Chandler 1.421
San Jose 1.018
Houston 978
Ann Arbor 865
Boardman 832
Dallas 803
Wilmington 774
Nyköping 764
Jacksonville 724
Seattle 643
Beijing 574
Dearborn 567
Cambridge 546
Helsinki 480
Los Angeles 330
Nanjing 287
Lauterbourg 235
Hong Kong 225
New York 225
Munich 223
Shanghai 221
Santa Clara 220
The Dalles 215
Boston 206
Hefei 195
Milan 194
Ho Chi Minh City 191
Rome 191
Hanoi 138
Seoul 137
Buffalo 131
San Diego 107
Shenyang 103
Guangzhou 91
Nanchang 87
São Paulo 84
Redwood City 78
Toronto 74
Orem 73
Dong Ket 72
Hebei 72
London 70
Jiaxing 68
Tianjin 64
Verona 62
Council Bluffs 60
Changsha 57
Norwalk 55
Atlanta 51
Frankfurt am Main 50
Sassari 50
Chicago 48
Tokyo 48
Redondo Beach 45
Mountain View 42
Jinan 41
Chennai 39
Warsaw 39
Da Nang 37
Tashkent 37
Brussels 36
Stockholm 35
Orange 34
Amsterdam 32
Phoenix 32
Brooklyn 31
Washington 31
Montreal 30
Rio de Janeiro 30
San Francisco 30
Wuhan 30
Zhengzhou 30
Baghdad 29
Kunming 29
Ningbo 28
Pune 28
Haiphong 27
Naples 27
Leawood 25
Nuremberg 25
Manchester 23
Auburn Hills 22
Dublin 22
Hangzhou 22
Porto Alegre 22
Augusta 21
San Mateo 21
Denver 20
Falls Church 20
Mumbai 20
Paris 19
Baku 18
Bologna 18
Dhaka 18
Totale 376.360
Nome #
Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1(B9) Drosophila melanogaster Genetic Model of Parkinson's Disease 5.419
Drosophila model for parkinson’s disease: function, anatomy and screening with phytoterapics from Sardinian and Indian flora (Withania somnifera and Mucuna pruriens) 5.070
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: drug effects of Withania somnifera (Dunal) administration 5.016
VGF protein and its C-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies 4.774
Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS 4.309
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.282
PROP bitter taste-induced brain activation-deactivation in gustatory signal processing: a functional magnetic resonance imaging (fMRI) study 4.194
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.075
OLFACTORY DYSFUNCTION AS POTENTIAL BIOMARKER IN NEURODEGENERATIVE DISORDERS 4.038
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 3.859
Morningness Eveningness Questionnaire (MEQ) and salivary DLMO determination: a reliable method of evaluation for circadian pattern 3.724
The neurosteroidogenic enzyme 5α-reductase mediates psychotic-like complications of sleep deprivation 3.705
Impaired sense of smell in a Drosophila Parkinson's model. 3.656
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 3.537
Brain activation pattern during perception of PROP bitter taste using functional magnetic resonance imaging (fMRI) 3.526
Drosophila Parkinson's mutant display olfactory impairment both to natural and synthetic compounds 3.503
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.469
F-Wave duration as a specific and sensitive tool for the diagnosis of restless legs syndrome/Willis-Ekbom disease 3.423
The re-organization of functional brain networks in pharmaco-resistant epileptic patients who respond to VNS 3.420
VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy 3.395
A multimodal neuroimaging approach in patients with early diagnosis of Parkinson's disease: Correlations between f-MRI with fine motor tasks, EEG and clinical tests 3.262
Parkinsonism and dementia are negative prognostic factors for the outcome of subdural hematoma 3.257
EEG functional network topology is associated with disability in patients with amyotrophic lateral sclerosis 3.242
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.176
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.110
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.099
null 2.940
TLQP peptides in amyotrophic lateral sclerosis: possible blood biomarkers with a neuroprotective role 2.936
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 2.934
Involvement of GABA in mirror focus: A case report 2.928
Influence of parkinsonism on Hitler's decision-making 2.908
Functional brain connectivity analysis in amyotrophic lateral sclerosis: an EEG source-space study 2.902
The effect of epoch length on estimated EEG functional connectivity and brain network organisation 2.805
VGF peptides as novel biomarkers in Parkinson’s disease 2.754
Polimorfismo Val66Met e valori di BDNF in pazienti affetti da epilessia farmacoresistente trattati con stimolazione del nervo vago (VNS). 2.737
Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients 2.709
Imaging and Genomic Classification of Brain Alteration Induced By Gustatory Bitter Stimulus, A Pilot Study 2.703
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.671
Networks in the brain: from neurovascular coupling of the BOLD effect to brain functional architecture 2.660
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.604
New vistas on VNS mechanism of action 2.599
Overlap Parasomnia Disorder in a case of Creutzfeldt-Jakob Disease 2.596
Reduction of fat mass by vagus nerve stimulation in rats 2.549
Vagus Nerve Stimulation Reduces Body Weight and Fat Mass in Rats 2.537
Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels 2.529
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.496
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.440
Clinical and genetic characteristics of late-onset Huntington's disease 2.410
Graph theory-based analysis of EEG during nREM sleep reveals changes in functional connectivity in sleep-related hypermotor epilepsy (SHE) 2.408
null 2.394
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.355
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.351
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 2.339
Blockade of 5-alpha reductase reduces compulsive behaviors in mice 2.304
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.302
Clinical manifestations of intermediate allele carriers in Huntington disease 2.280
Specificity and sensitivity of F-waves parameters in diagnosis of RLS/WED 2.230
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.208
Sleep motor activity in amyotrophic lateral sclerosis 2.198
Effects of vagus nerve stimulation on BDNF gene expression and hippocampal plasticity in the rat 2.166
Occurence and DAergic therapy correlates of REM sleep behavior disorder in patients with Parkinson Disease 2.160
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.156
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice 2.151
Neuroimaging, Networking and Systems Biology: The New Way to Investigate Pathologies with Neurological System Implications. The example of Tourette Syndrome as a Pilot Study 2.138
Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus 2.128
Suicide and Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease 2.123
Increase in 20-50 Hz (gamma frequencies) power spectrum and synchronization after chronic vagal nerve stimulation 2.094
Relationship of morningness-eveningness questionnaire score to Melatonin DLMO measured from saliva sample: circadian patterns of a normal subjects group and a delayed phase syndrome 2.075
How individual habits fit/unfit social norms: from the historical perspective to a neurobiological repositioning of an unresolved problem 2.071
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.057
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 2.011
Assessment of heart rate variability in a population of Sardinian patients affected by amyotrophic lateral sclerosis 2.011
A multivariate approach for the brain impairment in patients with liver cirrhosi 1.987
Chronic effects of vagus nerve stimulation on body fat mass in the rat 1.969
Reduction in rat body weight and fat mass without affecting food intake induced by vagus nerve stimulation 1.940
null 1.926
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 1.920
ECG-based cardiopulmonary coupling for sleep stability assessment in patients with amyotrophic lateral sclerosis 1.916
Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis 1.906
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.888
Loss of heart rate variability in ALS: Time and frequency domain assessment. 1.888
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.884
Discordance between Dopamine transporter deficit and motor symptoms in a case of REM sleep behavior disorder 1.883
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.868
The implication of neuroactive steroids in tourette's syndrome pathogenesis: A role for 5α-reductase? 1.848
Dissociation Between Neurovegetative Signs and Subjective Symptoms in a Case of Idiopathic Pilomotor Seizures 1.844
EEG spectral coherence analysis in nocturnal epilepsy 1.801
Role of DA-ergic therapy on REM sleep behaviour disorder in a large population of Parkinsonians 1.792
Spectral coherence analysis in EEG nocturnal epilepsy recordings 1.773
Respiratory sleep disorders in Jeune syndrome: a case description 1.754
Lack of antidepressant like behavioral effects of chronic vagus nerve stimulation in the rat despite neurochemical end molecular antidepressant like effects 1.753
Facial synkinesis as a first symptom of multiple sclerosis 1.748
Long-latency potential study in minimal hepatic hencephalopaty 1.746
Motor sleep features in a Sardinian population of amyotrophic lateral sclerosis patients. 1.709
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.687
Leucine-rich repeat kinase 2 (LRRK2) gene mutations in degenerative parkinsonism 1.680
Prevalence of Huntington's disease in Southern Sardinia, Italy 1.645
Long term vagus nerve stimulation (VNS) modifies EEG coherences and frequency power spectrum in partial epilepsy 1.638
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.617
Role of MR spectroscopy in patients with temporal lobe epilepsy (TLE) 1.595
Totale 262.202
Categoria #
all - tutte 489.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 489.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113.465 0 0 0 0 0 0 0 0 0 5.254 5.432 2.779
2021/202217.453 2.242 1.464 1.074 1.207 1.687 1.290 929 845 1.349 1.629 1.749 1.988
2022/202323.207 2.163 3.124 2.799 2.057 1.921 2.219 1.188 1.868 1.403 1.416 1.905 1.144
2023/202423.471 1.429 1.104 1.047 1.635 2.432 3.657 3.408 1.656 1.077 1.746 2.063 2.217
2024/202536.973 6.084 8.493 4.839 4.142 4.346 2.626 3.402 392 812 574 511 752
2025/202613.674 918 633 1.658 1.352 1.317 1.472 2.229 1.041 1.369 1.685 0 0
Totale 389.672